KEYNOTE-B49: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Pembrolizumab plus Chemotherapy in Patients with Hr+/Her2-Locally Recurrent Inoperable or Metastatic Breast Cancer

AuthID
 P-00X-EBM
20
Author(s)
Sohn, J
·
Gonzalez-Cortijo, L
·
Sonnenblick, A
·
Sabanathan, D
·
Korbenfeld, EP
·
Egle, D
·
Poirier, B
·
Zagouri, F
·
Matikas, A
·
Aksoy, S
·
Demirci, U
·
Ramos-Elias, P
·
Im, SA
·
Cardoso, F
·
Jia, L
·
Baccan, C
·
Tryfonidis, K
·
Schmid, P
Document Type
Abstract
Year published
2022
Published
in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X
Volume: 40, Issue: 16
Indexing
Wos®
Publication Identifiers
Wos: WOS:000863680304777
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service